Building Wireless Connectivity for Health Care


By Cindy Atoji

November 4, 2008 | BOSTON—Over the next three years, wireless mobile networks will evolve from today’s technology to next-generation capabilities, with open access allowing the use of any device or application on national bandwidths. But adoption will be slow until a standardized infrastructure is created, instead of every mobile company acting as a little fiefdom.

These were just some of the assessments made by telecommunications executives at a symposium entitled "Wireless and Mobile Services for Connected Health: What's Happening Now?" held in Boston last week, sponsored by the Center for Connected Health. And unless a viable business case is made for wireless—and until disparate industry groups learn to work together—there will be a “gap between what we are technically capable of doing and what we can actually do,” says Robert Schwarzberg, president and CEO of Sensei, a developer of mobile and web-based wellness solutions, including a cell-phone-based application for weight management. “The use of wireless or mobile is new to health, and like anything else, getting people to adopt ends up being the responsibility of us who are trying to find a way to engage them.”

A key platform for wireless health care is the cell phone, of course, said Schwarzberg and Verizon Wireless exec John Maschenic; with the increasing number of inexpensive cell phones and a variety of medical sensor devices, the cell phone as a diagnostic tool is a reality. With an estimated 3.5 billion cell phone users worldwide, text messaging in particular, already a $100 billion dollar business, will begin to be integrated into both health-IT systems and cell phones to manage and monitor health issues. “We’ll also see advancements in the use of videochat and smart band-aids, biosensors that interconnect through dedicated gateway devices or smart phones,” says Don Jones, vice president of business development for Qualcomm. Qualcomm plans to partner with carriers like Sprint Nextel or Verizon to launch a wireless mobile network that would allow people to use their cell phones to manage and monitor health issues, such as diabetes or dieting.

The success of the Apple iPhone has also created a tremendous opportunity in the wireless marketplace, with over 250 applications out of 6,000 related to health and lifestyles. “Apple is not a one-size-fits all solution, but just part of the ecosystem,” says Anand Iyer, head of WellDoc. “If you have a glucose meter, for example, it has to work across heterogeneous networks and encompass multiple devices and applications to deliver a measurable, and intangible health and economic outcome.”

To grow the wireless market, says Schwarzberg of Sensei, “it is the user experience that is critical, not the hardware. We need to create a value proposition that no one can deny and a way to have a user interface and experience that makes it so worthwhile that people will want to become engaged and empowered to do patient-centric health care. The technology is ready, but are we willing to adopt it?”

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .